Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: Clinical features of 27 patients

Clinical and Experimental Dermatology

Volumn 40, Issue 8, 2015, Pages 851-859

  Avancini, J ^a   Maragno, L ^a   Santi, C G ^a   Criado, P R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CARBAMAZEPINE; DAPSONE; METHYLPREDNISOLONE; NEVIRAPINE; PHENYTOIN; PREDNISONE; ALANINE AMINOTRANSFERASE; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ASSESSMENT; CLINICAL FEATURE; DEMOGRAPHY; DRESS SYNDROME; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; INVESTIGATIVE PROCEDURES; LABORATORY TEST; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; REGISTRY OF SEVERE CUTANEOUS ADVERSE REACTION SCORING SYSTEM; RETROSPECTIVE STUDY; SCORING SYSTEM; SOUTH AMERICAN; SOUTH AND CENTRAL AMERICA; TASK PERFORMANCE; CHEMICALLY INDUCED; DRUG HYPERSENSITIVITY SYNDROME; EOSINOPHILIA; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; RASH; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ANTI-INFECTIVE AGENTS; ANTICONVULSANTS; CHILD; DRUG HYPERSENSITIVITY SYNDROME; EOSINOPHILIA; EXANTHEMA; FEMALE; FEVER; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; YOUNG ADULT;

EID: 84947039844     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12682     Document Type: Article

References (27)

1. Bocquet H, Bagot M, Roujeau JC,. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg 1996; 15: 250-7.
2. Walsh SA, Creamer D,. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clin Exp Dermatol 2011; 36: 6-11.
3. Chaiken BH, Goldberg BI, Segal JP,. Dilantin sensitivity: report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. N Engl J Med 1950; 242: 897-8.
4. Roujeau JC, Stern RS,. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-85.
5. Peyriere H, Dereure O, Breton H, et al,. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2006; 155: 422-8.
6. Eshki M, Allanore L, Musette P, et al,. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol 2009; 145: 67-72.
7. Shear NH, Spielberg SP,. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 1988; 82: 1826-32.
8. Vittorio CC, Muglia JJ,. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995; 155: 2285-90.
9. Gentile I, Talamo M, Borgia G,. Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review. BMC Infect Dis 2010; 10: 49.
10. Criado PR, Criado RFJ, Avancini JM, Santi CG,. Drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS): a review of current concepts. An Bras Dermatol 2012; 87: 435-49.
11. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K,. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007; 156: 1083-4.
12. Bohan KH, Mansuri TF, Wilson NM,. Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care. Pharmacotherapy 2007; 27: 1425-39.
13. Sullivan JR, Shear NH,. The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 2001; 137: 357-64.
14. Cacoub P, Musette P, Descamps V, et al,. The DRESS syndrome: a literature review. Am J Med 2011; 124: 588-97.
15. Um SJ, Lee SK, Kim YH, et al,. Clinical features of drug-induced hypersensitivity syndrome in 38 patients. J Investig Allergol Clin Immunol 2010; 20: 556-62.
16. Chen YC, Chiu HC, Chu CY,. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol 2010; 146: 1373-9.
17. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al,. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007; 156: 609-11.
18. Ang CC, Wang YS, Yoosuff EL, Tay YK,. Retrospective analysis of drug-induced hypersensitivity syndrome: a study of 27 patients. J Am Acad Dermatol 2010; 63: 219-27.
19. Sontheimer RD, Houpt KR,. DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome. Arch Dermatol 1998; 134: 874-6.
20. Shiohara T, Inaoka M, Kano Y,. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 2006; 55: 1-8.
21. Husain Z, Reddy BY, Schwartz RA,. DRESS syndrome: part I. Clinical perspectives. Am Acad Dermatol 2013; 68: 693; quiz 706-698.
22. Lee JH, Park HK, Heo J, et al,. Drug Rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs. J Korean Med Sci 2008; 23: 521-5.
23. Kano Y, Ishida T, Hirahara K, Shiohara T,. Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome. Med Clin North Am 2010; 94: 743-59.
24. Criado P, Lucena S, APGS C, et al,. Síndrome de hipersensibilidade a anticonvulsivantes: relato de dois casos. Rev Bras Clin Terap 2002; 28: 59-63.
25. Husain Z, Reddy BY, Schwartz 10.000 RA,. DRESS syndrome: part II. Management and therapeutics. J Am Acad Dermatol 2013; 68: 709; quiz 718-20.
26. Kano Y, Hiraharas K, Sakuma K, Shiohara T,. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 2006; 155: 301-6.
27. Uhara H, Saiki M, Kawachi S, Ashida A, Oguchi S, Okuyama R,. Clinical course of drug-induced hypersensitivity syndrome treated without systemic corticosteroids. J Eur Acad Dermatol Venereol 2013; 27: 722-6.